ViaLase, Inc., a medical technology company pioneering noninvasive femtosecond laser treatments for glaucoma, today announced…
Arboretum_JDJuly 9, 2025
ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional…
Arboretum_JDApril 1, 2024
ViaLase Completes Enrollment for the Pivotal VIA-002 Trial of the ViaLase® Laser to Treat Primary Open Angle Glaucoma
ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma…
Arboretum_JDOctober 31, 2023
Vialase Announces Positive Results of First In-Human Study of Femtosecond Laser Image-Guided High-Precision Trabeculotomy (FLigHT)
ViaLase, Inc., a clinical stage medical technology company focused on addressing unmet needs in the…
Arboretum_JDMarch 3, 2023
ViaLase Founder and CEO Tibor Juhasz, PhD, Receives 2022 Golden Goose Award
ViaLase, Inc., announced that the company’s founder and CEO, Tibor Juhasz, Ph.D., was among five…
Arboretum_JDOctober 11, 2022
